New Systems of Health

There is universal consensus that some form of "connected care" will facilitate more effective research, accelerate scientific discovery, close the gap between knowledge and action, and improve health outcomes. Yet, in spite of many years of software development and billions of dollars of investment, the process of establishing functional national health infrastructures is deadlocked. Disconnected government policy, lack of continuity of care, poor information exchange, and fragmented service systems are persistent problems in the provision of health throughout the world.

'Health ecosystem design' is our solution to overcome fragmentation in healthcare. Pharmaceutical companies can use the concept to collaborate with integrated delivery networks (IDNs) and public health organizations to change the effect of disease worldwide. Health ecosystem design centers on reassembling building blocks to health to create a new standard of care, producing a new growth platform for a range of players simultaneously. In other words, prospects for new value propositions -- achieving differentiation and premium pricing, something most pharmaceutical companies and IDNs are struggling with -- will come from risk factor alignment through market alignment.

We see 'health ecosystem design' as a whole new strategy for growth in the pharmaceutical industry. Blue Spoon is the only consultancy in the world with a method to achieve this vision.

To learn more, click here to request our design concepts for malaria and diabetes